Skip to main content
Clinical Trials/CTRI/2016/08/007210
CTRI/2016/08/007210RecruitingPhase 3

EFFECT OF STRUCTURED TEACHING MODULE ON INCIDENCE OF THE CAPECITABINE INDUCED HAND FOOT SYNDROME IN PATIENTS OF COLORECTAL CANCER AT TERTIARY CANCER CARE CENTRE A PROSPECTIVE RANDOMISED CONTROLLED STUDY

Tata Memorial Hospital0 sites280 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
280

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • patients above age of 18 yrs
  • Planned for Capecitabine based chemotherapy for colorectal cancer in adjuvant or metastatic setting
  • Can either read or write English, or Hindi or Marathi.
  • Creatinine clearance > 60 ml/min
  • Receiving capectabine in dose of 2000mg/m2/day

Exclusion Criteria

  • Patients who are not willing to participate in the study
  • patients with previous history of hand foot syndrome
  • Previous exposure to 5-FU or Capecitabine < 1 year interval.
  • Chemotherapy regimens which increase capecitabine induced toxicities e.g. irinotecan induced diarrhea requiring dose reduction of both Capecitabine and irinotecan.
  • LFTs : AST/ALT > 3 ULN, bilirubin > 1.5 ULN, Albumin < 3.5

Investigators

Similar Trials